Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-62
Closed -$7.18K 955
2021
Q1
$7K Hold
62
﹤0.01% 633
2020
Q4
$7K Hold
62
﹤0.01% 611
2020
Q3
$7K Buy
62
+38
+158% +$4.07K ﹤0.01% 599
2020
Q2
$2K Hold
24
﹤0.01% 833
2020
Q1
$2K Sell
24
-15
-38% -$1.39K ﹤0.01% 812
2019
Q4
$4K Sell
39
-16
-29% -$1.49K ﹤0.01% 662
2019
Q3
$5K Buy
55
+35
+175% +$3K ﹤0.01% 590
2019
Q2
$2K Sell
20
-17
-46% -$1.33K ﹤0.01% 825
2019
Q1
$3K Sell
37
-6
-14% -$440 ﹤0.01% 728
2018
Q4
$3K Buy
43
+19
+79% +$1.33K ﹤0.01% 675
2018
Q3
$2 Buy
24
+6
+33% +$452 ﹤0.01% 785
2018
Q2
$1 Buy
18
+2
+13% +$148 ﹤0.01% 941
2018
Q1
$1K Buy
+16
New +$1.19K ﹤0.01% 876

Other funds holding FMC

Front Row Advisors's FMC Position: Q2 2021 in Review

Front Row Advisors sold out of FMC (FMC) in Q2 2021, closing a stake of 62 shares — an estimated $7.18K sold.

Front Row Advisors first reported a position in FMC in Q1 2018 and held it in 13 quarters. The position peaked at $7K in Q1 2021. 601 funds tracked by Wall St. Rank hold FMC as of Q2 2021.

  • Front Row Advisors reported no remaining FMC position as of Q2 2021 after selling out during the quarter.
  • Front Row Advisors sold 62 FMC shares in Q2 2021, an estimated $7.18K.
  • Front Row Advisors first reported a position in FMC in Q1 2018 and held it in 13 quarters.
  • Front Row Advisors's FMC position peaked at $7K in Q1 2021.
  • 601 funds tracked by Wall St. Rank held FMC as of Q2 2021.

Based on Front Row Advisors's 13F filing for Q2 2021, filed 23 Aug 2021.